RK Damani’s Derive Investments buys 26.5 lakh shares of Fortis Healthcare

NEW DELHI: RK Damani’s Derive Investments on Monday bought 26.5 lakh shares of Fortis Healthcare.

The firm bought 26,58,843 shares of Fortis Healthcare at Rs 144.50 apiece in a bulk deal, NSE data showed.

Shares of Fortis Healthcare on Monday gained over 7 per cent to settle at Rs 147.60 apiece on NSE.

Earlier this month, Delhi High Court allowed Daiichi Sankyo to enforce an international arbitration award so that it could recover Rs 3,500 crore from Fortis Healthcare’s promoters Malvinder Singh and Shivinder Singh, marking a victory for the Japanese company. Days after the verdict, Singh brothers quit the Fortis board.

In the latest development, the government has ordered a Serious Fraud Investigation Office (SFIO) probe against Fortis Healthcare and Religare Enterprises, which are at the centre of a controversy involving accusations of misconduct against their promoters Malvinder and Shivinder Singh, said a TNN report.

However, in a clarification submitted to BSE on Monday, the company said it had not received any such communication from government authority.

  • Related Posts

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    Over 10, 000 Km afar Australia & India shrank into an OT New Delhi: The chemistry between best in class ‘made in India’ surgical robotic system SSi Mantra and unique…

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    New ‘Bible’ of Nearly ‘Ideal’ Eating hit stands to become Instant Best Seller New Delhi: You are a veritable Hamlet when it comes to the question, to eat or not…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Nishant as Health Minister, Bihar is all set to witness a New Dawn of Healthcare

    Six Women Develop Serious Complications After C-Section

    Six Women Develop Serious Complications After C-Section

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Cracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses Detected

    Indian Pharma Majors Plan to Invest in US

    Indian Pharma Majors Plan to Invest in US

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr